Clinical evidence dossier
High-intensity interval exercise
Fasting Plasma Glucose (FPG)
Evidence signal
Evidence signal
Strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 4
- Supporting studies available for review
- 4
- Randomized trials
- 4
- Reported effects
- 9
Clinical conclusion
High-intensity interval exercise shows a strong positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
Observed effects
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 0
- Magnitude-eligible effects
- 0
Consistency
Consistency classification
Consistent
- Positive
- 4
- No effect
- 0
- Mixed
- 0
- Negative
- 0
Population and applicability
Structured population data were available for 4 of 4 supporting studies. 3 studies described participants with type 2 diabetes. 4 studies described adult participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Adults aged 18-65 with type 2 diabetes.
- Individuals looking for effective exercise interventions to manage diabetes.
- Adults diagnosed with diabetic peripheral neuropathy.
- Patients with type 2 diabetes experiencing complications.
- Individuals seeking alternative exercise regimens for metabolic health.
- Adults diagnosed with type 2 diabetes.
- Individuals seeking effective exercise interventions for diabetes management.
- Adults aged 30-60 with pre-diabetes
- Individuals looking to improve body composition and metabolic health
Limitations
- Evidence uses heterogeneous comparison contexts: active_comparator, usual_care.
- 2 of 4 studies with duration data have follow-up of 12 weeks or less.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.